Upbeat trial data from Amgen Inc. (Nasdaq: AMGN) for its PCSK9 lifted shares of The Medicines Company (Nasdaq: MDCO) $7.96 to close at $45.96, which has a similar product in development, and Esperion Therapeutics Inc. (Nasdaq: ESPR) $3.72 to close at $16.44. Amgen stock soared $7.95 to close at $167.53.
Upbeat Amgen data lifts rivals
February 03, 2017 at 18:10 PM EST
